Get the Stockscreener App
0.4501
2.10%
-0.0175
Cosmos Health Inc stock is traded at $0.4501, with a volume of 208.64K.
It is down -2.10% in the last 24 hours and up +3.72% over the past month.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.
See More
Previous Close:
$0.4676
Open:
$0.49
24h Volume:
208.64K
Relative Volume:
0.34
Market Cap:
$16.81M
Revenue:
$53.55M
Net Income/Loss:
$-15.13M
P/E Ratio:
-0.4168
EPS:
-1.08
Net Cash Flow:
$-23.86M
1W Performance:
-12.05%
1M Performance:
+3.72%
6M Performance:
-7.33%
1Y Performance:
-33.43%
1-Day Range:
$0.448
$0.49
1-Week Range:
$0.448
$0.57
52-Week Range:
$0.2801
$1.32
Cosmos Health Inc Stock (COSM) Company Profile
Name
Cosmos Health Inc
Sector
Industry
Phone
312-536-3102
Address
5 AGIOU GEORGIOU, PILEA, THESSALONIKI
Compare COSM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COSM
Cosmos Health Inc
|
0.4501 | 17.46M | 53.55M | -15.13M | -23.86M | -1.08 |
|
MCK
Mckesson Corporation
|
834.62 | 101.70B | 387.09B | 4.23B | 6.01B | 32.12 |
|
COR
Cencora Inc
|
349.20 | 67.10B | 321.33B | 1.57B | 3.21B | 7.9518 |
|
CAH
Cardinal Health Inc
|
212.09 | 49.48B | 234.31B | 1.61B | 4.45B | 6.6243 |
|
HSIC
Henry Schein Inc
|
75.45 | 8.93B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.45 | 796.34M | 2.22M | -5.63M | -1.68M | -0.24 |
Cosmos Health Inc Stock (COSM) Latest News
Cosmos Health CEO Siokas buys $57,000 in shares - Investing.com India
Sunday’s Insider Activity: Big Buys at Zenas, Hycroft, and Major NVDA Sell - Investing.com Nigeria
Is Cosmos Health Inc. stock a defensive play in 2025July 2025 Trends & Accurate Intraday Trading Signals - Улправда
Cosmos Health Announces Launch Of Food Supplement Brand In Albania: Retail Sentiment Improves - MSN
Is Cosmos Health Inc. stock a safe haven assetStability vs Neutral Overview & support options for steady strides - Улправда
Cosmos Health Inc.Common Stock (NQ: COSM - FinancialContent
Insider Stock Purchases: January 09, 2026 - Quiver Quantitative
Cosmos Health CEO Siokas buys $81,000 in shares By Investing.com - Investing.com Canada
Cosmos Health CEO Siokas buys $81,000 in shares - Investing.com
Why Cosmos Health Inc. stock could see breakout soonPortfolio Profit Report & Consistent Profit Alerts - Улправда
Why Cosmos Health Inc. (V67A) stock could be next leaderDividend Hike & Verified Technical Signals - Улправда
How Cosmos Health Inc. stock reacts to Fed rate cutsEarnings Overview Report & Daily Price Action Insights - Улправда
How currency fluctuations impact Cosmos Health Inc. stockJuly 2025 Snapshot & Fast Moving Trade Plans - ulpravda.ru
Layoff Watch: What catalysts could drive Cosmos Health Inc stock higherWeekly Volume Report & Free Technical Pattern Based Buy Signals - moha.gov.vn
Why Cosmos Health Inc. (V67A) stock trades below fair valueMarket Weekly Review & Technical Buy Zone Confirmation - ulpravda.ru
Why Cosmos Health Inc. stock could benefit from AI revolutionJobs Report & Expert Approved Momentum Ideas - Улправда
Cosmos Health CEO Siokas buys $65,000 in COSM stock By Investing.com - Investing.com South Africa
Cosmos Health CEO Siokas buys $65,000 in COSM stock - Investing.com
How Cosmos Health Inc. stock benefits from strong dollarJuly 2025 Closing Moves & Short-Term High Return Ideas - ulpravda.ru
Analysis Recap: How Cosmos Health Inc. stock reacts to Fed rate cuts2025 Institutional Moves & AI Driven Stock Movement Reports - Улправда
Insider Stock Purchases: January 07, 2026 - Quiver Quantitative
Cosmos Health CEO Siokas buys $72k in shares By Investing.com - Investing.com UK
Cosmos Health CEO Siokas buys $72k in shares - Investing.com
Cosmos Health to manufacture PathMuscle drug for Greek distributor By Investing.com - Investing.com Nigeria
Cosmos Health’s Wild Ride: Can COSM Survive Its Own Volatility? - AD HOC NEWS
Tangible book value per share of Cosmos Health Inc – MUN:V67A - TradingView — Track All Markets
Cosmos Health (COSM) Subsidiary to Manufacture PathMuscle for Li - GuruFocus
Cosmos Health stock rises on manufacturing deal with Libytec By Investing.com - Investing.com Nigeria
Cosmos Health stock rises on manufacturing deal with Libytec - Investing.com
Cosmos Health Inc. Subsidiary Cana Laboratories Enters Manufacturing Agreement for PathMuscle with Libytec Pharmaceutical in Greece - Quiver Quantitative
Cosmos Health to manufacture PathMuscle drug for Greek distributor - Investing.com
Cosmos Health Enters Manufacturing Agreement with Libytec - GlobeNewswire
About Us - FinancialContent
Cosmos Health Enters Manufacturing Agreement with Libytec for PathMuscle Medicine, with Five-Year Volumes Expected to Exceed 1.2 Million Units - Sahm
Cosmos Health Is Building a Platform, and Tariffs Are Accelerating the Strategy - ACCESS Newswire
How one healthcare supplier is remaking its business to dodge tariffs - Stock Titan
Cosmos Health receives Nasdaq non-compliance bid price notice - MSN
Siokas buys Cosmos Health (COSM) shares worth $43,000 By Investing.com - Investing.com Australia
Siokas buys Cosmos Health (COSM) shares worth $43,000 - Investing.com India
Cosmos Health CEO Acquires Shares Through Debt Exchange - TradingView — Track All Markets
Will Cosmos Health Inc. (V67A) stock benefit from mergers2025 Macro Impact & Weekly Return Optimization Plans - Улправда
Cosmos Health Inc Stock (COSM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cosmos Health Inc Stock (COSM) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Siokas Grigorios | Chief Executive Officer |
Jan 08 '26 |
Buy |
0.52 |
156,190 |
81,000 |
7,131,794 |
| Siokas Grigorios | Chief Executive Officer |
Jan 07 '26 |
Buy |
0.52 |
124,880 |
65,000 |
6,975,604 |
| Siokas Grigorios | Chief Executive Officer |
Jan 06 '26 |
Buy |
0.54 |
133,953 |
72,000 |
6,850,724 |
| Siokas Grigorios | Chief Executive Officer |
Dec 19 '25 |
Buy |
0.49 |
88,314 |
43,000 |
6,716,771 |
| Siokas Grigorios | Chief Executive Officer |
Dec 15 '25 |
Buy |
0.42 |
168,472 |
70,000 |
6,628,457 |
| Siokas Grigorios | Chief Executive Officer |
Nov 28 '25 |
Buy |
0.64 |
76,360 |
49,000 |
6,459,985 |
| Siokas Grigorios | Chief Executive Officer |
Nov 25 '25 |
Buy |
0.63 |
55,732 |
35,000 |
6,383,625 |
| Siokas Grigorios | Chief Executive Officer |
Nov 21 '25 |
Buy |
0.68 |
56,080 |
38,000 |
6,327,893 |
| Siokas Grigorios | Chief Executive Officer |
Nov 20 '25 |
Buy |
0.62 |
51,315 |
32,000 |
6,271,813 |
| Siokas Grigorios | Chief Executive Officer |
Nov 19 '25 |
Buy |
0.65 |
61,614 |
40,000 |
6,220,498 |
0.00%
3.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):